Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q2 2022 Program Management Update

8 Aug 2022 07:00

RNS Number : 1706V
R&Q Insurance Holdings Ltd
08 August 2022
 

R&Q Insurance Holdings Ltd.

 

Q2 2022 Program Management Update

 

GWP grows by over 80% to $807 million for the first half of 2022

 

8 August 2022

 

R&Q Insurance Holdings Ltd, (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business for the first six months of the year ending 30 June 2022.

 

Highlights

 

· Gross Written Premium ('GWP') of $807 million (H1 2021: $445 million), an 82% increase

 

· Program Fee Income of $39 million (H1 2021: $19 million), a 105% increase1

 

· 75 programs (YE 2021: 69 programs), an increase of 6 programs

 

· Continued to expand MGA network and partnerships:

Post period-end, two new programs were approved, and we agreed to add $100 million to our existing partnership with Corvus Insurance

Hosted inaugural European and US MGA forums with hundreds of attendees and leading MGAs from the US, UK, and Europe

 

William Spiegel, Executive Group Chairman, commented:

 

"Our Program Management business produced another very strong period of growth in the first half of 2022. All three of our platforms (US Admitted, US Non-Admitted, and Europe) grew GWP and Fee Income relative to the year-ago period. Our pipeline of additional MGA partnerships and growth opportunities remains robust as our R&Q Accredited franchise continues to grow its reputation with both MGAs and reinsurers as a leading place to do business. This is reflected in the additional number of scale partnerships we have signed in the first half of 2022. Since the end of the first quarter, we also held inaugural MGA forums in the US and Europe where our Program Management partners met, exchanged ideas, heard from industry experts, and forged new business opportunities. This is just one of the ways in which we are building a differentiated proposition relative to peers.

 

"Additionally, despite rising interest rates and volatile financial markets, we note that our investment portfolio is well positioned with our assets significantly shorter in duration than our liabilities and over 95% comprising liquid, investment grade fixed income securities and cash. Our portfolio has not experienced any credit impairments."

 

Notes:

1. Program Fee Income is on a written basis and excludes our share of earnings from minority stakes in MGAs.

 

Ends

 

Enquiries to:

 

Randall & Quilter Investment Holdings Ltd

William Spiegel

Tel: 0207 780 5850

Tom Solomon

Tel: 0207 780 5850

Alan Quilter Tel: 020 7780 5960

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls 

Tel: 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker)

Nish Amin

Chris Madderson

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

Tel: 020 7632 2322

FTI Consulting

Tom Blackwell

 

Tel: 020 3727 1051

 

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a non-life global specialty insurance company operating two highly complementary, businesses: Program Management and Legacy Insurance. Both of these businesses are leaders in markets with high barriers to entry and significant growth opportunities. Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSIESWEESESA
Date   Source Headline
10th May 20232:30 pmRNSTR-1: Notification of major holdings
10th May 202311:26 amRNSTR-1: Notification of major holdings
4th Apr 20237:00 amRNSStrategic & Trading Update
31st Mar 20237:00 amRNSAppointment of Non-Executive Chairman
17th Mar 20237:00 amRNSCompletion of Tradesman Sale
3rd Mar 202312:16 pmRNSTR-1: Notification of major holdings
23rd Feb 20237:00 amRNSProgram Management Update and Sale of Tradesman
17th Jan 20237:00 amRNSProgram Management Update
12th Jan 20237:00 amRNSPDMR/Director Shareholding and Total Voting Rights
6th Jan 20237:00 amRNSJoint venture to acquire legacy liabilities
5th Dec 20227:00 amRNSLoss Portfolio Transfer
31st Oct 20227:00 amRNSQ3 2022 Program Management Update
19th Oct 20224:40 pmRNSSecond Price Monitoring Extn
19th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 20229:24 amRNSTR-1: Notification of major holdings
17th Oct 202210:32 amRNSTR-1: Notification of major holdings
3rd Oct 20223:59 pmRNSDirector/PDMR Shareholding
13th Sep 20222:26 pmRNSResult of Special General Meeting
6th Sep 202212:45 pmRNSTR-1: Notification of major holdings
5th Sep 20227:00 amRNSResults for the half year ended 30 June 2022
30th Aug 20227:00 amRNSResponse to Phoenix
24th Aug 20227:00 amRNSNotice of special general meeting
22nd Aug 20227:00 amRNSBoard Appointment
12th Aug 20226:20 pmRNSResponse to requisition
8th Aug 20227:00 amRNSQ2 2022 Program Management Update
2nd Aug 202210:05 amRNSTR-1: notification of major holdings
19th Jul 20227:00 amRNSChange of Company Name
14th Jul 20223:03 pmRNSResult of Annual General Meeting
14th Jul 202212:47 pmRNSTR-1: Notification of major holdings
14th Jul 202212:45 pmRNSTR-1: Notification of major holdings
14th Jul 202210:46 amRNSTR-1: Notification of major holdings
13th Jul 20223:57 pmRNSTR-1: Notification of major holdings
13th Jul 20223:57 pmRNSTR-1: Notification of major holdings
13th Jul 20223:54 pmRNSTR-1: Notification of major holdings
13th Jul 20222:15 pmRNSTR-1: Notification of major holdings
12th Jul 20222:03 pmRNSTR-1: Notification of major holdings
11th Jul 20223:44 pmRNSResults of General Meeting and Open Offer
6th Jul 20223:56 pmRNSTR-1: Notification of major holdings
1st Jul 20227:00 amRNSTR-1: notification of major holdings
1st Jul 20227:00 amRNSTR-1: notification of major holdings
1st Jul 20227:00 amRNSTR-1: notification of major holdings
20th Jun 20224:00 pmRNSNotice of Annual General Meeting and Annual Report
17th Jun 20224:30 pmRNSPosting of Circular and Notice of General Meeting
16th Jun 202210:15 amRNSTR-1: notification of major holdings
16th Jun 202210:09 amRNSTR-1: Notification of major holdings
14th Jun 20228:00 amRNSUpdate on Fundraise and Legal Settlement
13th Jun 20227:00 amRNSProposed Placing and Open Offer
13th Jun 20227:00 amRNSResults for the year ended 31 December 2021
30th May 20227:00 amRNSQ1 2022 Program Management Update
25th May 20226:11 pmRNSResult of Special General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.